|
|
|
|
| See the bigger picture in DEL screening data. This webinar explores how analyzing the full dataset, not just top hits, can uncover meaningful structure-function trends across chemical series. Learn how a broader view can sharpen early synthesis decisions, strengthen series selection, and help discovery teams prioritize smarter while reducing downstream risk in discovery programs. Click here to learn more. |
|
|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | “When I came to Florida,” James Sapirstein says, “I was leaving New Jersey because of tax reasons.” That was 2018. Timing is everything, they say. Sapirstein’s relocation placed him ahead of a broadening and intensifying migration trend – including he believes, a new biotechnology settlement. This is not news to readers – Miami alone seems perennially in the headlines. “Economics drives investors,” Sapirstein says, and Sapirstein is committed spearheading “a new kind of biotech cluster." | |
|
|
Fostering Effective Sponsor–CDMO Collaboration (Trust vs. Oversight) | | This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right,” addresses how to balance trusting a CDMO as a subject-matter expert with maintaining sufficient oversight through clear KPIs, targeted on-site presence at critical milestones, and a partnership mindset where both sides work to enable each other’s success and demonstrate ongoing trustworthiness. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Science To Success: CMC Strategies That Drive Market Readiness | Article | By Neha Shah, Ph.D., and Kiran Pedada, Ph.D., Bend Bioscience | Learn how a scientifically grounded framework for early-phase CMC development, integrating QbD and proactive risk management, helps de-risk drug development and accelerate the journey to market. |
|
|
| Nasal Delivery: Strategies For Success | Article | MedPharm | A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain patient access. |
|
|
| Robotics And AI In Pharma: Driving The Next Wave Of Innovation | Article | By Victoria Morgan, West Pharmaceutical Services, Inc. | Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies. |
|
|
|
Bring Advanced ASD Tech Into Your Lab | | A lab‑ready leasing program offers solvent‑free dispersion technology for rapid prototyping, broader formulation options, hands‑on development, and technical support—without capital investment. |
|
|
|
|
| Connect With Outsourced Pharma: |
|
|
|
